HighTower Advisors LLC cut its holdings in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 35.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 51,709 shares of the company’s stock after selling 27,859 shares during the quarter. HighTower Advisors LLC’s holdings in ARK Genomic Revolution ETF were worth $1,318,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Chris Bulman Inc purchased a new stake in shares of ARK Genomic Revolution ETF during the second quarter valued at $36,000. Larson Financial Group LLC boosted its stake in shares of ARK Genomic Revolution ETF by 4,576.1% during the second quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock valued at $78,000 after purchasing an additional 3,249 shares during the period. First Horizon Advisors Inc. boosted its stake in shares of ARK Genomic Revolution ETF by 9.4% during the second quarter. First Horizon Advisors Inc. now owns 4,650 shares of the company’s stock valued at $109,000 after purchasing an additional 398 shares during the period. Hilltop Holdings Inc. purchased a new stake in shares of ARK Genomic Revolution ETF during the third quarter valued at $237,000. Finally, Sanctuary Advisors LLC purchased a new stake in shares of ARK Genomic Revolution ETF during the second quarter valued at $222,000.
ARK Genomic Revolution ETF Stock Up 2.2 %
ARKG stock opened at $25.25 on Tuesday. The company has a fifty day moving average price of $24.76 and a 200-day moving average price of $25.10.
ARK Genomic Revolution ETF Company Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Articles
- Five stocks we like better than ARK Genomic Revolution ETF
- Canada Bond Market Holiday: How to Invest and Trade
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Transportation Stocks Investing
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- The How And Why of Investing in Oil Stocks
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
